Keyphrases
Nitric Oxide
100%
Tolerability
100%
Knee Osteoarthritis
100%
Cyclooxygenase-1 (COX-1)
100%
Safety Self-efficacy
100%
Hip Osteoarthritis
100%
Donator
100%
Naproxcinod
100%
Systolic Blood Pressure
50%
Rofecoxib
50%
Placebo
25%
Treatment Group
25%
Analysis of Covariance
25%
Group Differences
25%
Change from Baseline
25%
Subscale Scores
25%
WOMAC
25%
Osteoarthritis
12%
Rheumatology
12%
Optimal Dose
12%
Adverse Events
12%
Anti-inflammatory Drugs
12%
Vital Signs
12%
Pain Score
12%
Group Studies
12%
Active Treatment
12%
Twice Daily
12%
Once-daily
12%
Dose Finding
12%
Difference in Mean
12%
Safety Endpoints
12%
Confirmatory Trials
12%
Fixed Factors
12%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Osteoarthritis
100%
Prostaglandin Synthase
100%
Naproxcinod
100%
Nitric Oxide
100%
Rofecoxib
50%
Placebo
25%
Clinical Trial
12%
Adverse Event
12%
Antiinflammatory Agent
12%